Fallowfield LJ - Search Results

1

Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B.

Fallowfield LJ, Leaity SK, Howell A, Benson S, Cella D. Fallowfield LJ, et al. Breast Cancer Res Treat. 1999 May;55(2):189-99. doi: 10.1023/a:1006263818115. Breast Cancer Res Treat. 1999. PMID: 10481946

2

Assessment of quality of life in breast cancer.

Fallowfield LJ. Fallowfield LJ. Acta Oncol. 1995;34(5):689-94. doi: 10.3109/02841869509094050. Acta Oncol. 1995. PMID: 7546841 Review.

3

A daily diary for quality of life measurement in advanced breast cancer trials.

Fraser SC, Ramirez AJ, Ebbs SR, Fallowfield LJ, Dobbs HJ, Richards MA, Bates T, Baum M. Fraser SC, et al. Among authors: fallowfield lj. Br J Cancer. 1993 Feb;67(2):341-6. doi: 10.1038/bjc.1993.62. Br J Cancer. 1993. PMID: 8431363 Free PMC article. Clinical Trial.

4

Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life.

Fraser SC, Dobbs HJ, Ebbs SR, Fallowfield LJ, Bates T, Baum M. Fraser SC, et al. Among authors: fallowfield lj. Br J Cancer. 1993 Feb;67(2):402-6. doi: 10.1038/bjc.1993.74. Br J Cancer. 1993. PMID: 8431375 Free PMC article. Clinical Trial.

5

Attitudes of patients to randomised clinical trials of cancer therapy.

Fallowfield LJ, Jenkins V, Brennan C, Sawtell M, Moynihan C, Souhami RL. Fallowfield LJ, et al. Eur J Cancer. 1998 Sep;34(10):1554-9. doi: 10.1016/s0959-8049(98)00193-2. Eur J Cancer. 1998. PMID: 9893627

6

Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for 'well-tolerated' treatments?

Fellowes D, Fallowfield LJ, Saunders CM, Houghton J. Fellowes D, et al. Among authors: fallowfield lj. Breast Cancer Res Treat. 2001 Mar;66(1):73-81. doi: 10.1023/a:1010684903199. Breast Cancer Res Treat. 2001. PMID: 11368413

7

The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively.

Coster S, Poole K, Fallowfield LJ. Coster S, et al. Among authors: fallowfield lj. Breast Cancer Res Treat. 2001 Aug;68(3):273-82. doi: 10.1023/a:1012278023233. Breast Cancer Res Treat. 2001. PMID: 11727963

8

Quality of life: a new perspective for cancer patients.

Fallowfield L. Fallowfield L. Nat Rev Cancer. 2002 Nov;2(11):873-9. doi: 10.1038/nrc930. Nat Rev Cancer. 2002. PMID: 12415257 Review. No abstract available.

9

The effects of hormone therapy on cognition in breast cancer.

Shilling V, Jenkins V, Fallowfield L, Howell T. Shilling V, et al. J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):405-12. doi: 10.1016/j.jsbmb.2003.07.001. J Steroid Biochem Mol Biol. 2003. PMID: 14623538

10

Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study.

Jenkins V, Shilling V, Fallowfield L, Howell A, Hutton S. Jenkins V, et al. Psychooncology. 2004 Jan;13(1):61-6. doi: 10.1002/pon.709. Psychooncology. 2004. PMID: 14745746 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters